Asston Pharmaceuticals Ltd — Important, 30-03-2026: Company Update

Asston Pharmaceuticals has announced significant board changes. The company appointed Mr. Sumit Pawar as Chief Financial Officer, bringing expertise in finance, accounting, and strategy. Mr. Yashvardhan Tupe joins as an Additional Non-Executive Director, expected to contribute to growth and governance with his manufacturing sector experience. Mr. Sandip Sharma was appointed as an Additional Non-Executive Independent Director, enhancing the board with his corporate law and compliance knowledge. The board also approved calling an Extraordinary General Meeting, which will be held via video conferencing. These appointments aim to strengthen the company’s leadership and strategic capabilities.